Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Open-Label Extension Study to Evaluate the Long-Term Safety of Cenobamate Adjunctive Therapy in Subjects With Primary Generalized Tonic-Clonic Seizures

NCT03961568 is registered in ClinicalTrials.gov with SK Life Science, Inc. as lead sponsor.

NCT NCT03961568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03961568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Open-Label Extension Study to Evaluate the Long-Term Safety of Cenobamate Adjunctive Therapy in Subjects With Primary Generalized Tonic-Clonic Seizures
Lead sponsor
SK Life Science, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 13, 2019
Completion date
June 10, 2026
Enrollment
147 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

primary generalized tonic clonic seizures in the setting of idiopathic generalized epilepsy